AIM
ABBV icon

Acrospire Investment Management’s AbbVie ABBV Stock Holding History

Acrospire Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,604
Closed -$189K – 6
2017
Q2 		$189K Buy
2,604
+1,800
+224% +$121K 0.18% 28
2017
Q1 		$52K Sell
804
-400
-33% -$25.1K 0.04% 900
2016
Q4 		$75K Sell
1,204
-2,400
-67% -$146K 0.03% 1119
2016
Q3 		$227K Buy
3,604
+900
+33% +$58.3K 0.15% 97
2016
Q2 		$167K Sell
2,704
-2,300
-46% -$140K 0.12% 152
2016
Q1 		$286K Buy
+5,004
New +$279K 0.2% 56

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Acrospire Investment Management's ABBV Position: Q3 2017 in Review

Acrospire Investment Management sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 2,604 shares — an estimated $189K sold.

Acrospire Investment Management first reported a position in ABBV in Q1 2016 and held it in 6 quarters. The position peaked at $286K in Q1 2016. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Acrospire Investment Management reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,604 AbbVie shares in Q3 2017, an estimated $189K.
  • Acrospire Investment Management first reported a position in AbbVie in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's AbbVie position peaked at $286K in Q1 2016.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.